Stockscreener 앱 받기
4.19
4.75%
0.19
Elutia Inc 주식(ELUT)의 최신 뉴스
ELUTElutia Inc. Latest Stock News & Market Updates - StockTitan
Elutia Inc. (NASDAQ:ELUT) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St
Elutia Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Cantor Fitzgerald Reaffirms Overweight Rating for Elutia (NASDAQ:ELUT) - Defense World
Elutia's (ELUT) "Overweight" Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Gr - GuruFocus.com
Elutia Inc (ELUT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Challenges By GuruFocus - Investing.com Canada
Elutia Inc. (ELUT) Quarterly 10-Q Report - Quartzy
Elutia Inc. Reports Strong Q3 Results, Prepares for Major Product Launch - TipRanks
Elutia Inc (ELUT) Q3 2024 Earnings: EPS of $0.03 Beats Estimates, Revenue of $5.92M Misses Expectations - GuruFocus.com
Elutia earnings beat by $0.11, revenue fell short of estimates - Investing.com UK
Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025 - The Manila Times
Elutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - The Manila Times
What To Expect From Elutia Inc (ELUT) Q3 2024 Earnings - GuruFocus.com
Elutia (ELUT) to Release Earnings on Thursday - Defense World
Elutia (ELUT) Set to Announce Earnings on Thursday - MarketBeat
Short Interest in Elutia Inc. (NASDAQ:ELUT) Rises By 7.4% - MarketBeat
Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024 - The Manila Times
Elutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30 - The Manila Times
Individual investors among Elutia Inc.'s (NASDAQ:ELUT) largest stockholders and were hit after last week's 10% price drop - Simply Wall St
Contaminated donor tissue gave Georgia patient tuberculosis, lawsuit says - The Atlanta Journal Constitution
SILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia Inc - GuruFocus.com
Preclinical Data Show Efficacy Of Elutia's Antibiotic-Eluting BioEnvelope - MPO-mag
Preclinical Data Show Efficacy of Elutia’s Antibiotic-Eluting BioEnvelope - MPO-mag
Elutia (NASDAQ:ELUT) vs. Curis (NASDAQ:CRIS) Head to Head Comparison - Defense World
Nantahala Capital Management LLC Grows Stock Position in Elutia Inc. (NASDAQ:ELUT) - Defense World
Nantahala Capital Management LLC Purchases 145,697 Shares of Elutia Inc. (NASDAQ:ELUT) - MarketBeat
Short Interest in Elutia Inc. (NASDAQ:ELUT) Declines By 30.1% - MarketBeat
Elutia Inc. (NASDAQ:ELUT) Sees Large Decrease in Short Interest - Defense World
Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices - StockTitan
Short Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 10.9% - MarketBeat
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators - HMP Global Learning Network
Elutia announces first patient implant of EluPro, the world’s first drug-eluting bioenvelope for cardiac pacemakers and neurostimulators - Cardiovascular Business
AIGH Capital Management LLC Increases Position in Elutia Inc. (NASDAQ:ELUT) - MarketBeat
Cantor Fitzgerald Reiterates “Overweight” Rating for Elutia (NASDAQ:ELUT) - Defense World
Elutia Celebrates First Year - ForexTV.com
Elutia (NASDAQ:ELUT) Receives Overweight Rating from Cantor Fitzgerald - MarketBeat
Elutia Announces First Patient Implant of EluPro™, the - GlobeNewswire
Elutia to Participate in Upcoming Investor Conferences - ForexTV.com
Ryan Marques Joins Elutia As VP Of Operations - MPO-mag
Short Interest in Elutia Inc. (NASDAQ:ELUT) Expands By 468.3% - Defense World
Ryan Marques Joins Elutia as VP of Operations - MPO-mag
Elutia Inc. (NASDAQ:ELUT) Short Interest Update - MarketBeat
Spine Implant Caused Patient's TB, Suit Says - Law360
ELUT (Elutia) Financial Strength : 2 (As of Jun. 2024) - GuruFocus.com
ELUT (Elutia) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com
Elutia Inc. (ELUT) Q2 2024 Earnings Call Transcript - Seeking Alpha
Elutia (NASDAQ:ELUT) Price Target Cut to $10.00 - MarketBeat
Elutia Wins FDA Clearance Of Its Antibiotic-Eluting BioEnvelope - MPO-mag
0.65%
자본화:
|
볼륨(24시간):